The recommendations come at a time when treatments for chronic lymphocytic leukemia (CLL), such as venetoclax, are making deep remissions and undetectable minimal residual disease (MRD) after a fixed ...
Test detects genetic abnormalities to aid in the prediction of chronic lymphocytic leukemia patient survival. Abbott received 510k clearance for an in vitro diagnostic test to aid in determining the ...
In a first for the disease, there is now an FDA-approved companion diagnostic and drug pairing intended to treat a specific population of leukemia patients. Some patients with a common type of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results